高级别浆液性卵巢癌输卵管切除预防机会缺失的规模评估
该多机构回顾性混合方法研究纳入2015至2021年两家学术医疗中心的1877例高级别浆液性癌(HGSC)患者,并调查917名自报HGSC患者(其中348例确诊)。回顾队列中23.7%存在输卵管切除预防机会缺失,调查受访者中为15.5%;有受累一级亲属者中基因检测及反射性降低风险手术的机会缺失率达43.2%。
要点
- HGSC患者中相当比例曾接受可同期行输卵管切除的手术而未实施预防。
- 45岁及以上因胆囊切除、疝修补、肠道手术等就诊者是补做预防的潜在窗口。
- 有受累一级亲属者基因检测与降低风险手术的机会缺失率较高。
核心结论
- 相当比例的HGSC患者错过了基因检测风险评估与手术预防的机会。
- 鉴于HGSC缺乏有效筛查且治疗选择有限,消除该病需解决全谱系的机会缺失。
研究设计与样本
- 多机构回顾性混合方法研究,纳入2015至2021年两家学术医疗中心诊断的1877例HGSC患者。
- 同时对某全国性卵巢癌组织成员开展电子调查,917名受访者中348例确诊HGSC。
- 数据分析时间为2023年5月至2023年8月。
主要发现
- 回顾队列中445例(23.7%)存在输卵管切除机会缺失。
- 445例中241例(54.2%)曾行输卵管结扎或子宫切除,204例(45.8%)曾行其他腹盆腔手术。
- 45岁及以上患者较年轻患者更常接受胆囊切除、疝修补与肠道手术。
- 348名调查受访者中54例(15.5%)报告机会缺失。
- 有受累一级亲属者中基因检测及反射性降低风险手术的机会缺失率为43.2%。
关键数值与推荐
- 机会缺失定义:任何年龄曾行导致永久避孕的手术(双侧输卵管结扎或未同期行输卵管切除的子宫切除),或45岁及以上曾行其他腹盆腔手术且该手术早于HGSC诊断1年及以上、本可同期行输卵管切除。
- 主要结局指标为本可经输卵管切除预防的HGSC比例。
临床怎么用
- 对拟行输卵管结扎、子宫切除或其他腹盆腔手术的患者评估同期输卵管切除的可行性。
- 对45岁及以上接受胆囊切除、疝修补、肠道手术者考虑转诊评估降低风险手术。
- 对有一级亲属受累的HGSC患者家系补做基因检测并衔接降低风险手术。
局限性
- 原文未报告具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The impact of salpingectomy on the prevention of high-grade serous cancer (HGSC) at the population level is currently under investigation. OBJECTIVE: To determine the frequency of missed opportunity for salpingectomy with/without oophorectomy among patients diagnosed with HGSC. DESIGN, SETTING, AND PARTICIPANTS: This mixed-methods, multi-institutional retrospective study included patients diagnosed with HGSC at 2 academic medical centers between 2015 and 2021. Clinicopathologic data were abstracted from medical records. An electronic survey was also administered to members of a national ovarian cancer organization who self-identified as having had an HGSC diagnosis. The retrospective cohort included 1877 patients with HGSC and the survey included 917 respondents, of which 348 were diagnosed with HGSC. These data were analyzed from May 2023 and August 2023. EXPOSURE: Missed opportunity was defined as a history of either a surgical procedure resulting in permanent contraception (bilateral tubal ligation or hysterectomy without concurrent salpingectomy) at any age or another abdomino-pelvic surgery at 45 years or older when salpingectomy could have been performed 1 year or more preceding a diagnosis of HGSC. MAIN OUTCOME AND MEASURE: The proportion of HGSCs that could have been prevented with salpingectomy. RESULTS: Of the 445 patients (23.7%) with missed opportunities for salpingectomy in the retrospective cohort, 241 had a tubal ligation/hysterectomy (54.2%) and 204 had other abdomino-pelvic surgeries (45.8%). Cholecystectomy, hernia repair, and bowel surgeries were more commonly performed for patients 45 years or older than for younger patients. Among the 348 survey respondents, missed opportunity was reported by 54 (15.5%). The study team uncovered a 43.2% missed opportunity rate for germline genetic testing and reflex risk-reducing surgery among patients with an affected first-degree relative in the retrospective cohort. CONCLUSIONS AND RELEVANCE: A considerable proportion of patients with HGSC missed opportunities for risk assessment with genetic testing and for surgical prevention. Given the lack of effective screening and limited treatment options for HGSC, eradicating it requires addressing the full spectrum of missed opportunities.
引用
- Moufarrij S, Hazimeh D, Rockwell T, et al. Gauging the Magnitude of Missed Opportunity for Ovarian Cancer Prevention. JAMA Surg. 2025. PMID: 40802262. doi:10.1001/jamasurg.2025.2810
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。